Sarah Bronner

Sarah Bronner began their work experience in 2003 at Intel Corporation as an iHIP intern, where they worked until 2006. In 2012, they joined the California Institute of Technology as an NIH Postdoctoral Fellow, and stayed until 2014. From 2014 to 2019, Sarah worked at Genentech as a Scientist in Medicinal Chemistry. Currently, they are working at Maze Therapeutics, starting in 2019 as a Senior Scientist II and later being promoted to Associate Director of Medicinal Chemistry in March 2022.

Sarah Bronner attended UCLA from 2007 to 2012, where they earned a Doctor of Philosophy (PhD) degree in Chemistry. Prior to that, they studied at UC San Diego from 2003 to 2007, graduating with a Bachelor of Science (BS) degree in Chemistry. Information regarding their time at Caltech is not provided.